http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200927131-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f63ab6c11118c953a881c304751384c |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K101-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-02 |
filingDate | 2007-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c88555d29d0af8017953855516fcde8d |
publicationDate | 2009-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-200927131-A |
titleOfInvention | Halogenated xanthine derivatives and precursors thereof for anti-cancer and anti-metastasis activity and preparing method thereof |
abstract | The halogenated xanthine derivatives and the precursors thereof for anti-cancer and anti-metastasis activity and the preparing method thereof are provided. The halogenated xanthine derivatives can further be radio labeled. The growth of human prostate carcinoma, tongue squamous cell carcinoma, colon adenocarcinoma and lung carcinoma can be inhibited and arrested in G0/G1 phase by KMUP-2Cl (7-[2-[4-(chlorophenyl)-piperazinyl]ethyl]-1, 3-dimethyl-8-chloroxant hine). In addition, the growth of human prostate carcimona LNCaP can be inhibited by KMUP-1 (7-[2-[4-(2-chlorobenzene)-piperazinyl]-ethyl]-1, 3-dimethyl-xanthine), and the LNCaP prostate cancer xenograft growth in nude mice is effectively inhibited by the intraperitoneal injection and per oral administration of KMUP-1. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I386206-B |
priorityDate | 2007-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 367.